Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History GHRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics GHRS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

GH Research PLC

GHRS
Current price
11.68 USD -0.46 USD (-3.79%)
Last closed 12.31 USD
ISIN IE000GID8VI0
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 734 428 096 USD
Yield for 12 month -1.43 %
1Y
3Y
5Y
10Y
15Y
GHRS
21.11.2021 - 28.11.2021

GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland. Address: Joshua Dawson House, Dublin, Ireland, D02 RY95

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

33.14 USD

P/E ratio

Dividend Yield

Financials GHRS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures GHRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-315 000 USD

Last Year

-315 000 USD

Current Quarter

Last Quarter

EBITDA -51 455 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -11.97 %
PEG Ratio
Return On Equity TTM -16.20 %
Wall Street Target Price 33.14 USD
Revenue TTM
Book Value 5.00 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.79 USD
Diluted Eps TTM -0.79 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation GHRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -11.97
Price Book MRQ 2.40

Technical indicators GHRS

For 52 weeks

6.00 USD 20.50 USD
50 Day MA 10.88 USD
Shares Short Prior Month 2 851 684
200 Day MA 9.74 USD
Short Ratio 18.41
Shares Short 2 857 451
Short Percent 16.50 %